{"schema":"hottub-news/story/v1","story":"st_wfrfqvlszvyv7pymvzsq","title":"MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/mink-therapeutics-to-present-data-on-treatment-resistant-colorectal-wfrfqvlszv","count":1,"items":[{"id":"n_wfrfqvlszvyv7pymvzsq","seq":1348135,"kind":"press_release","title":"MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026","url":"https://www.globenewswire.com/news-release/2026/10/02/3373825/0/en/mink-therapeutics-to-present-data-on-treatment-resistant-colorectal-cancer-and-clearance-of-senescent-tumor-cells-and-fibroblasts-at-sitc-2026.html","summary":"NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT ), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat immune-mediated diseases and cancer, today announced two poster presentations at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting. The presentations address two distinct areas of cancer research: tumor-cell killing in…","published":"2026-10-02T13:00:00Z","seen":"2026-10-02T13:07:57Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:inkt","us6036931029"],"entities":[{"id":"Q16900986","name":"Swinomish Indian Tribal Community","type":"event"}],"mentions":2,"story":"st_wfrfqvlszvyv7pymvzsq","category":"health","category_p":0.46000000834465027,"sentiment":"neutral","tone":0.14000000059604645,"political":0.18000000715255737}]}